Facebook
Twitter
LinkedIn
ForwardAUGUST 2022
The Diagnostic Odyssey for Individuals with Rare Diseases: Pompe Disease and Other Lysosomal Storage Diseases
Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. Please join us as Dr. Jennifer Cohen explores the recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. She will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.
August 9, 1–2 p.m. ET
Live, Accredited Webcast
OCTOBER 2022
31st Annual National Conference
October 17–19, Bloomington, Minnesota
Learn about important advances and the hottest topics in the care and management of medically complex patients.
Live, Onsite Conference
The Diagnostic Odyssey for Individuals with Rare Diseases: Achondroplasia and Other Causes of Disproportionate Short Stature
October 27, 1–2 p.m. ET
There are many different conditions that can cause disproportionate short stature, but achondroplasia is the most common skeletal dysplasia found in humans, accounting for 90% of cases of disproportionate short stature. Please join us as Dr. Gary Bellus explores the recent advances in the diagnosis and treatment of achondroplasia and other causes of disproportionate short stature. He will also share the importance of the interprofessional team to provide insights, perspectives, and strategies to support the well-being of both the individual and their family/caregiver(s).
Live, Accredited Webcast
NOVEMBER 2022
2022 Optimal Care Grand Rounds Series: New Trends in Cardiology Imaging
November 2, 6–7 p.m. ET or 8–9 p.m. ET
Optimal Care focuses on the quadruple aim to improve patient outcomes while decreasing low value or wasted care. This is the fourth of a multisession, accredited series and will provide primary care providers (PCPs) with actionable content that addresses evidence-based diagnosis and treatment approaches for many of the high-priority complex diseases frequently encountered in practice. This activity will discuss CCTA as a new trend in cardiology imaging and its role in providing a comprehensive assessment of patients with suspected CAD.
Live, Accredited Webcast
The Diagnostic Odyssey for Individuals with Rare Diseases: Kaposiform Lymphangiomatosis and Other Lymphatic Conditions
November 10, 1–2 p.m. ET (Postponed from Sept. 15)
Kaposiform lymphangiomatosis (KLA) is a rare, life-threatening congenital lymphatic malformation. Please join us as Dr. Denise Adams explores the recent advances in the diagnosis and treatment of KLA and other lymphatic conditions, including current clinical trials. She will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s).
Live, Accredited Webcast
Missed the live webcast?
Click on the title to take the on-demand webcast(s).
The Diagnostic Odyssey for Individuals with Rare Diseases: Pompe Disease and Other Lysosomal Storage Diseases
Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. Please join us as Dr. Jennifer Cohen explores the recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. She will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.
Advanced Degenerative Joint Disease and Chronic Lower Back Pain: Evidence-Based Approaches to Care
This is the third of a multisession, accredited series. This session will focus on evidence-based management approaches to advanced degenerative joint disease (DJD) and chronic lower back pain (CLBP). It will discuss the effectiveness of current common interventions, including the utility and role of multimodal rehabilitation therapy, epidural steroid injections (ESI), joint fusion procedures,
and nerve stimulation modalities aimed at reducing pain.
Systemic Mastocytosis: Diagnostic and Therapeutic Updates
Systemic mastocytosis (SM) is often called “the great imitator.” Its symptoms are frequently complex and can mimic those of several other disorders. Individuals can suffer for years before being correctly diagnosed. Please join us as Dr. Daniel DeAngelo reviews the symptoms and signs of SM, provides an overview of new and current therapies and identifies SM guideline updates. The value of an interdisciplinary team-based approach along the continuum of care will also be discussed.
New Trends in the Management of Asthma and Chronic Obstructive Pulmonary Disease
This is the second of a multisession, accredited series. This session will discuss newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses. Emerging trends in asthma and COPD management will also be discussed.
Healing Racial Trauma Through Somatic Anti-Racism Practices
The effects of experienced and on-going trauma have a long-lasting impact on mental and physical health, behavioral tendencies and social relationships, including those within the workplace. This activity will identify the multifaceted effects of past and continuous trauma—including collective and racial trauma—on the well-being of individuals, cultures, communities, and social environments. It will review racism and oppressive tendencies and present strategies to skillfully manage difficult racial and cultural situations and their associated stressful responses. Importantly, trauma management therapies and practices will be identified, along with approaches to building communal anti-racist culture within the workplace.
Non-Alcoholic Fatty Liver Disease
This session will discuss the prevalence, diagnosis and factors that contribute to the development of non-alcoholic fatty liver disease (NAFLD). Best practices for the treatment of individuals with NAFLD will also be discussed.
Across the Sexual Orientation and Gender Identity Spectrum: A Call to Action
This activity will provide health care providers with increased awareness surrounding these issues so that communication with LGBTQ+ people is respectful and sensitive. It will review how patient-provider interactions can be more supportive of the individual’s needs, how to take a full history and perform an inclusive and affirming physical exam, and how health information can be thoughtfully documented to provide accurate information regarding health issues, screening recommendations and risk prevention.
The Diagnostic Odyssey for Individuals With Rare Diseases: Leukodystrophies
This activity will explore recent advances in the diagnosis and treatment of leukodystrophies, including current clinical trials. It will also share insights and perspectives from individuals and their family/caregiver(s) and provide strategies to support their well-being.